Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-09-23
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults
NCT07181551
Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals
NCT06654414
Connection to Health for Smokers
NCT03680599
SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups
NCT05029362
Tobacco Cessation in Postmenopausal Women
NCT01210586
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRANSform your health
A culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina
TRANSform your health
A culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TRANSform your health
A culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Fundación Huésped
OTHER
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Cartujano, MD
Assistant Professor - Department of Public Health Sciences (SMD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francisco Cartujano, MD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación Huésped
Buenos Aires, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FH-077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.